跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 53 条关于
“OX40R”
全部
53
临床试验
20
药物
27
机构
0
资讯
6
去年
Kyowa Kirin to Present Phase 3 Rocatinlimab Results for Atopic Dermatitis at EADV 2025
去年
FDA Clears IND Application for Novel Monoclonal Antibody OX40 Antagonist for Atopic Dermatitis
6个月前
ImageneBio Secures $30M Funding to Advance OX40 Antagonist IMG-007 Through Phase 2 Trials
10个月前
ImageneBio Advances Anti-OX40 Antibody IMG-007 with Protocol Amendment for Phase 2b Atopic Dermatitis Trial
去年
Former Poseida CEO Kristin Yarema Named to Lead Ikena-Inmagene Merger as Companies Advance Anti-OX40 Therapy
去年
Inmagene Initiates Phase 2b Trial of IMG-007 Anti-OX40 Antibody for Moderate-to-Severe Atopic Dermatitis